Response to fibrolamellar hepatocellular carcinoma versus conventional hepatocellular carcinoma: better 5-year survival or artefactual result of research methodology?
Gut
.
2014 Sep;63(9):1524.
doi: 10.1136/gutjnl-2013-306407.
Epub 2013 Nov 28.
Authors
Tobias Eggert
1
,
Katherine McGlynn
1
,
Tim F Greten
2
,
Sean Altekruse
2
Affiliations
1
MOB, NIH, Bethesda, Maryland, USA.
2
NCI, Center for Cancer Research, Bethesda, Maryland, USA.
PMID:
24287277
PMCID:
PMC6309552
DOI:
10.1136/gutjnl-2013-306407
No abstract available
Keywords:
LIVER.
Publication types
Letter
Comment
MeSH terms
Carcinoma, Hepatocellular / mortality*
Humans
Liver Neoplasms / mortality*
Research Design*
Supplementary concepts
Fibrolamellar hepatocellular carcinoma
Grants and funding
Z99 CA999999/Intramural NIH HHS/United States